Document is current

Any future updates will be listed below

Radiation dosimetry of the α4β2 nicotinic receptor ligand (+)-[18F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results

Crossref DOI link: https://doi.org/10.1186/s40658-016-0160-5

Published Online: 2016-10-21

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark